Company intelligence / Profile preview

Borregaard

Ownership: Private
Employees: ~1100
Development stage: Commercial

Overview

Borregaard operates one of the world’s most advanced biorefineries using wood as a raw material to produce sustainable biochemicals—including APIs and intermediates for pharma—alongside biomaterials like specialty cellulose, lignin products, bioethanol, vanillin, and fine chemicals. The company serves multiple industries including agriculture, construction, foodstuffs, batteries/biofuels—and pharmaceuticals via its CMO/CDMO services.

Modalities: Small molecule
Industry: Contract Manufacturing Organization

Partnerships

Not specifically disclosed; acts as CMO/CDMO partner for various pharmaceutical companies.

Beyond the preview

Go deeper on Borregaard.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Borregaard.

Explore the full profile